Relpax
Product Images NDC 54868-5528

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Relpax (NDC 54868-5528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (40 mg Tablet Blister Pack)

Relpax 40 mg label displaying the lot number 0000 and an expiration date of 01/60. The label includes the NDC 54868-5528-06 and indicates distribution by Physicians Total Care, Inc. The image shows a barcode and packaging details for Relpax tablets.*

FDA Label Image

Chemical Structure (Relpax 01)

Chemical structure of the active ingredient in Relpax, illustrating its molecular composition including a sulfonyl group, an indole ring, and a pyrrolidine moiety, shown as a hydrobromide salt.*

FDA Label Image

Figure 1 (Relpax 02)

A line graph titled 'Estimated Probability of Initial Headache Response Within 2 Hours,' plotting estimated probability of response against time from initial dose in hours. It compares response probabilities for double blind placebo and eletriptan doses of 20 mg, 40 mg, and 80 mg over a 2-hour period.*

FDA Label Image

Figure 2 (Relpax 03)

A line graph showing the estimated probability of taking a second dose or other medication over 24 hours following the first dose. The x-axis represents time from the initial dose in hours, and the y-axis represents the probability. The graph compares multiple groups: double blind placebo and eletriptan at doses of 20 mg, 40 mg, and 80 mg.*

FDA Label Image

Logo (Relpax 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.